Business UpdateJun 1, 2026, 04:01 PM
Keros CEO to Present at Goldman Sachs Healthcare Conference
AI Summary
Keros Therapeutics, Inc. announced that its President and Chief Executive Officer, Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at the Goldman Sachs 47th Annual Global Healthcare Conference. The event is scheduled for Monday, June 8, 2026, at 4:00 p.m. Eastern time, with a live audio webcast and an archived replay available for investors. Keros is a clinical-stage biopharmaceutical company developing novel therapeutics for disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins.
Key Highlights
- Keros Therapeutics CEO Jasbir S. Seehra to present at Goldman Sachs 47th Annual Global Healthcare Conference.
- Fireside chat scheduled for Monday, June 8, 2026, at 4:00 p.m. Eastern time.
- A live audio webcast of the presentation will be available online.
- An archived replay will be accessible for up to 90 days on the Keros website.
- Keros is a clinical-stage biopharmaceutical company focused on TGF-ß family protein signaling disorders.
- Rinvatercept is being developed for Duchenne muscular dystrophy and amyotrophic lateral sclerosis.
- Elritercept is being developed for cytopenias in myelodysplastic syndrome and myelofibrosis.
Price Impact
More from KROS